Frontiers in Cardiovascular Medicine (May 2022)

Transcatether Aortic Valve Implantation to Treat Degenerated Surgical Bioprosthesis: Focus on the Specific Procedural Challenges

  • Cristina Aurigemma,
  • Francesco Burzotta,
  • Francesco Burzotta,
  • Rocco Vergallo,
  • Piero Farina,
  • Enrico Romagnoli,
  • Stefano Cangemi,
  • Stefano Cangemi,
  • Francesco Bianchini,
  • Marialisa Nesta,
  • Piergiorgio Bruno,
  • Piergiorgio Bruno,
  • Domenico D'Amario,
  • Antonio Maria Leone,
  • Carlo Trani,
  • Carlo Trani

DOI
https://doi.org/10.3389/fcvm.2022.895477
Journal volume & issue
Vol. 9

Abstract

Read online

Actually transcatheter aortic valve implantation within failed surgically bioprosthetic valves (VIV-TAVI) is an established procedure in patients at high risk for repeat surgical aortic valve intervention. Although less invasive than surgical reintervention, VIV-TAVI procedure offers potential challenges, such as higher rates of prosthesis-patient mismatch and coronary obstruction. Thus, optimal procedural planning plays an important role to minimize the risk of procedure complications. In this review, we describe the key points of a VIV-TAVI procedure to optimize outcomes and reduce the risk of procedure complications.

Keywords